03/29/2011

Notice of Changing Corporate Name

03/28/2011

Notice of Granting Paid Stock Option

03/01/2011

Notice of Changing independent Auditor

03/01/2011

Agenda for the 10th Annual General Shareholder Meeting

02/15/2011

Announcement of the 10th Annual General Shareholder Meeting

02/15/2011

Notice of Changing Corporate Name and Amendment of Article of Incorporation

11/29/2010

Notice of investments in China

11/16/2010

Notice of Increasing the Capital of Shanghai Genomics

10/20/2010

GNI Receives F351 Patent Allowance in Japan

09/17/2010

Shanghai Genomics Issued US Patent Covering F351

08/26/2010

GNI Receives F351 Patent Allowance in Canada

07/30/2010

Notice of reaching agreement for co-development of F351 in China

07/26/2010

Shanghai Genomics Reports Human Phase I Trial Data of F351

06/21/2010

Shanghai Genomics Ltd. and Immuno-Biological Laboratories Co., Ltd. Signed Licensing Agreement to Explore Chinese Market

04/12/2010

Notice of Exercise Price of Stock Option etc